Product image of Medikinet (Methylphenidate Hydrochloride) supplied by GNH India

Medikinet

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Medikinet (Methylphenidate Hydrochloride)

Methylphenidate hydrochloride, the active ingredient in Medikinet, is a central nervous system stimulant presented as an oral tablet for oral use. It is prescribed to manage symptoms of attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults.

GNH India supplies Medikinet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution. Customers benefit from reliable logistics, batch traceability, and responsive technical support throughout the supply chain.

Manufacturer / TM Owner

Medice Arzneimittel Pütter Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medikinet (methylphenidate) is a central nervous system stimulant that modulates neurotransmitter activity to enhance attention and wakefulness in specific disorders.

  • Attention deficit hyperactivity disorder (ADHD): improves concentration, reduces hyperactivity and impulsivity.
  • Narcolepsy: decreases excessive daytime sleepiness and improves alertness.
  • ADHD in children: enhances academic performance and behavioral control.

How It Works

  • Methylphenidate blocks the reuptake of dopamine and norepinephrine at neuronal synapses, increasing their extracellular concentrations. The elevated catecholamine levels stimulate post‑synaptic receptors in the prefrontal cortex and other brain regions, leading to enhanced attention, reduced impulsivity, and increased wakefulness.

Side Effects

Common side effects are usually mild to moderate and may lessen with continued therapy.

Common Side Effects

  • Insomnia: difficulty falling or staying asleep.
  • Decreased appetite: reduced hunger leading to weight loss.
  • Headache: mild to moderate cranial pain.
  • Stomach pain: abdominal discomfort or nausea.
  • Increased heart rate: mild tachycardia.
  • Irritability: heightened emotional reactivity.

Serious or Rare Side Effects

  • Cardiovascular events: hypertension, arrhythmia, or chest pain.
  • Psychiatric symptoms: new or worsening psychosis, mania, or severe anxiety.
  • Seizures: occurrence of convulsive episodes.
  • Allergic reaction: rash, swelling, or anaphylaxis.
  • Growth suppression: notable decrease in height velocity in children.
  • Peripheral vasculitis: inflammation of small blood vessels.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate cardiovascular, psychiatric, and seizure risk factors.

  • Cardiovascular assessment: monitor blood pressure and heart rate regularly.
  • Psychiatric screening: watch for emergence of psychosis, mania, or severe anxiety.
  • Seizure history: avoid use in patients with uncontrolled seizure disorders.
  • Allergy check: discontinue if signs of hypersensitivity appear.
  • Growth monitoring: track height and weight in pediatric patients.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Methylphenidate may interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Antihypertensive agents: may reduce blood pressure‑lowering effect.
  • Anticonvulsants: can lower seizure threshold.

Moderate Interactions (Monitor Closely):\n- CYP2D6 inhibitors (e.g., fluoxetine): may increase methylphenidate plasma levels.

  • Selective serotonin reuptake inhibitors (SSRIs): potential for increased serotonergic activity.
  • Alcohol: may exacerbate central nervous system stimulation and cardiovascular effects.

Frequently Asked Questions

Medikinet contains methylphenidate and is prescribed for attention deficit hyperactivity disorder (ADHD) and narcolepsy. In ADHD it helps improve focus, reduce hyperactivity, and control impulsive behavior, while in narcolepsy it lessens excessive daytime sleepiness and promotes wakefulness.

Methylphenidate blocks the reuptake of dopamine and norepinephrine, increasing their levels in the synaptic cleft. The heightened neurotransmitter activity stimulates receptors in the prefrontal cortex and other brain areas, which enhances attention, reduces impulsivity, and promotes alertness.

The appropriate dose of Medikinet is determined individually by a qualified prescriber based on the patient’s age, weight, clinical response, and tolerability. Dosage adjustments are made during follow‑up visits to achieve optimal therapeutic effect while minimizing side effects.

Safety data for methylphenidate in pregnancy and lactation are limited. Healthcare providers should weigh potential benefits against possible risks to the fetus or infant. If treatment is necessary, it should be prescribed only after a thorough risk‑benefit assessment by the prescriber.

To request Medikinet, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Medikinet (methylphenidate) is a central nervous system stimulant similar to other methylphenidate formulations and to amphetamine‑based products. Compared with amphetamines, methylphenidate generally has a slightly lower risk of cardiovascular stimulation but may differ in onset, duration and individual tolerability.

Medikinet should be stored at room temperature, below 25 °C, in the original packaging. Keep the tablets away from moisture, direct sunlight, and heat sources to maintain potency and stability throughout its shelf life.

Medikinet is taken orally, usually with water. The tablet is swallowed whole and should be taken at the time(s) prescribed by the healthcare professional, often in the morning and/or early afternoon to avoid interference with sleep.

Serious risks include cardiovascular events such as hypertension or arrhythmia, psychiatric effects like new or worsening psychosis or mania, seizures, and severe allergic reactions. Patients should be monitored regularly, and any concerning symptoms should prompt immediate medical evaluation.

Medikinet is contraindicated in individuals with known hypersensitivity to methylphenidate, those currently taking monoamine oxidase inhibitors, patients with severe cardiovascular disease, uncontrolled hypertension, or a history of serious psychiatric disorders such as psychosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT